Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2019
Historique:
received: 30 11 2018
revised: 13 03 2019
accepted: 30 04 2019
entrez: 19 6 2019
pubmed: 19 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

It is difficult to control small hepatocellular carcinoma (HCC) nodules adjacent to the Glisson sheath (GS) by trans-arterial chemoembolization (TACE) probably due to multiple small tumor feeders directly branching from the trunk artery. The purpose of this study was to conduct a retrospective evaluation of a new TACE technique called the repeated alternate infusion of cisplatin solution and gelatin slurry distal to balloon occlusion (RAIB-TACE), for the treatment of small HCC nodules adjacent to GS. Small nodules less than 4 cm attached to proximal portion of the subsegmental to lobar level portal branch were retrospectively selected. Between January 2011 and April 2014, 29 nodules in 29 patients were treated by super-selective lipiodol TACE/balloon-occluded TACE (B-TACE) (Lip-TACE group). Since April 2014, treatment protocols for small nodules adjacent to GS were changed, and 14 nodules in 12 patients were treated by RAIB-TACE (RAIB-TACE group). In RAIB-TACE group, alternate infusion of cisplatin solution and sparse gelatin slurry (mixture of 80 mg of gelatin fragments and 20 mL of contrast medium) were repeated until arterial flow was ceased. In Lip-TACE group, lipiodol was used as drug carrier and dense gelatin slurry (mixture of 80 mg of gelatin fragments and 2 mL of contrast medium) as embolization material. Dynamic CT/MRI was obtained 1-3 months after TACE, and response of each nodule was evaluated basing on modified RECIST criteria. In RAIB-TACE group, all 14 nodules (100%) were diagnosed as CR or PR. In Lip-TACE group, 18 of 29 (62.1%) were diagnosed as CR or PR. There was a statistically significant difference in objective response ratio between the groups (p=0.008, Fisher's test). Biloma (n=1) and benign stricture of the right hepatic duct (n=1) were seen in RAIB-TACE group. The biloma shrunk without treatment and the patient had no symptom, but the patient with biliary stricture repeated cholangitis and was treated by administration of antibiotics. The study results show that RAIB-TACE is more effective than lipiodol TACE/B-TACE for small hepatocellular carcinoma adjacent to GS. We speculate that one of the reasons to explain why Lip-TACE is inferior to RAIB-TACE is that viscous lipiodol or dense gelatin slurry could not flow into small tumor feeders effectively.

Identifiants

pubmed: 31211142
doi: 10.1155/2019/8350926
pmc: PMC6532302
doi:

Substances chimiques

Ethiodized Oil 8008-53-5
Gelatin 9000-70-8
Cisplatin Q20Q21Q62J

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8350926

Références

Hepatology. 2000 Feb;31(2):269-79
pubmed: 10655246
Ann Surg Oncol. 2000 Sep;7(8):593-600
pubmed: 11005558
J Vasc Interv Radiol. 2003 Dec;14(12):1535-42
pubmed: 14654488
Radiology. 2005 Oct;237(1):361-5
pubmed: 16118153
Cardiovasc Intervent Radiol. 2007 Jul-Aug;30(4):696-704
pubmed: 17497071
Jpn J Radiol. 2009 May;27(4):185-93
pubmed: 19499310
Semin Liver Dis. 2010 Feb;30(1):52-60
pubmed: 20175033
Eur J Radiol. 2012 Sep;81(9):1976-9
pubmed: 21628086
Cardiovasc Intervent Radiol. 2012 Oct;35(5):980-5
pubmed: 22009576
J Vasc Interv Radiol. 2012 Oct;23(10):1278-85
pubmed: 22922041
Cardiovasc Intervent Radiol. 2013 Jun;36(3):706-13
pubmed: 22996589
J Vasc Interv Radiol. 2013 Aug;24(8):1235-40
pubmed: 23796857
Br J Cancer. 2013 Oct 1;109(7):1904-7
pubmed: 24008659
Jpn J Radiol. 2014 May;32(5):260-5
pubmed: 24615165
AJR Am J Roentgenol. 2014 Dec;203(6):W706-14
pubmed: 25415737
Oncology. 2014;87 Suppl 1:22-31
pubmed: 25427730
J Hepatol. 2015 May;62(5):1187-95
pubmed: 25681552
Hepatol Res. 2016 Mar;46(3):E100-4
pubmed: 25988271
Jpn J Radiol. 2015 Dec;33(12):790-4
pubmed: 26390870
Jpn J Clin Oncol. 2018 Feb 1;48(2):103-114
pubmed: 29253194
Nihon Igaku Hoshasen Gakkai Zasshi. 1987 Dec 25;47(12):1550-9
pubmed: 3452788
Radiology. 1983 May;147(2):357-64
pubmed: 6836115

Auteurs

Toshiyuki Irie (T)

Department of Radiology, Hitachi General Hospital, Japan.

Nobuyuki Takahashi (N)

Department of Radiology, Tsukuba Memorial Hospital, Japan.

Toshiro Kamoshida (T)

Department of Hepato-Gastroenterology, Hitachi General Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH